OPER Technology Limited was set up by Dr Cathy Lui (right) and Professor Ken Yung, Associate Head of the Department of Biology of HKBU and Chairman of the Company.


薈新科技由雷雅萍博士(右)及該公司主席、浸大生物系副系主任翁建霖教授(左)成立。

Professor Cheah Kok-wai (centre) and his start-up wins the Certificate of Merit, Technology Start-up Award at the Sixth Bank of China (HK) FITMI Achievement Award.


謝國偉教授(中)及他的初創企業獲頒第六屆中銀香港「初創科技」潛能大獎優異獎。

Date: 16 Nov 2016 (Wednesday)

Archive

HKBU spin-off companies win two more start-up awards

兩間浸大科技初創企業再奪兩獎

HKBU spin-off companies OPER Technology Limited and Cathay Photonics Ltd each won more awards recently for their novel patented technologies.

Biotech company OPER Technology Limited won second prize (entrepreneurial category) at the 5th China Innovation and Entrepreneurship Competition (Hong Kong, Macau and Taiwan regions). The award was for its pioneering neural stem cell harvest technology that could in future be used to treat neurological problems such as Parkinson’s disease. One of 27 shortlisted enterprises from Hong Kong and Taiwan, OPER Technology Limited passed two rounds of competition to win this prize out of the six finalists.

Dr Cathy Lui, an alumna who is concurrently an HKBU Senior Research Associate of the Department of Biology and CEO of the Company, said, “It was our honour to represent Hong Kong in this tough competition, which is one of the largest of its kind in mainland China.” The competition attracted enterprises from Hong Kong, Macau and Taiwan to showcase their innovations and expand their business opportunities in mainland China.

Meanwhile, Cathay Photonics Ltd received the Certificate of Merit in the Technology Start-up Award under the Sixth Bank of China (HK) FITMI Achievement Award, organised by the Hong Kong Federation of Innovative Technologies and Manufacturing Industries Ltd (FITMI) and Bank of China (Hong Kong). The award was gained for the Company’s invention of ultra-hard, non-fragile and scratch resistant covers for use on electronic devices. The judging panel said that the invention can be applied for use on many touch screen devices and has gained many international awards and recognition. The Company was founded by a group of physicists and engineers led by Professor Cheah Kok-wai, Chair Professor of the Department of Physics of HKBU.

Both technology start-ups aim to commercialise their research findings at HKBU by making use of the Government’s Innovation and Technology Commission fund.

兩間浸大科技初創企業薈新科技有限公司和國泰光電有限公司最近再奪得兩項科技獎。

薈新科技有限公司獲得第五屆中國創新創業大賽(港澳台賽)企業組亞軍。該公司憑著研發一項幹細胞療法,有望可治療神經退化疾病如柏金遜症的技術,成為香港及台灣兩地候選的共27間企業,再經兩輪比賽,打入最終六強,奪得亞軍。

浸大校友、生物系高級副研究員及薈新科技有限公司總裁兼雷雅萍博士說﹕「我們能夠代表香港參與這項內地的大型比賽感到榮幸。」該項比賽集合了來自香港、澳門、台灣的企業展示創新科技,有助到中國內地開展業務。

此外,國泰光電有限公司獲頒由香港創新科技及製造業聯合總會及中國銀行(香港)合辦的第六屆中銀香港「初創科技」潛能大獎優異獎。該公司研發出可用於輕觸式顯示屏的超硬、強韌、抗刮薄膜。評審認為,是項研發「可以廣泛應用於多種電子產品的屏幕上,並已經贏得多個國際性獎項,備受國際科技學術界的肯定。」國泰光電有限公司由浸大物理系講座教授謝國偉教授率領的一班物理學家及工程師組成。

兩間科技初創企業利用創新科技署的撥款資助創立企業,將浸大的科研成果商品化。